Dr. Eric S. Molho, MD

Dr. Molho practices at Albany Medical Center in Albany, New York, part of Albany Med Health System.

Dr. Molho's NPI, 1427042399, was assigned on September 7, 2005. Dr. Molho graduated from Albany Medical College in 1987. Dr. Molho holds New York license 180686-1.

Dr. Molho's primary practice is Albany Medical Center, at 43 New Scotland Avenue, Mail Code 34, Albany, NY 12208 in Albany County. The practice phone is (518) 262-2400.

Dr. Molho's primary practice is Albany Medical Center in Albany, New York, part of Albany Med Health System. Dr. Molho is also affiliated with Samaritan Hospital. The medical group on file is Albany Med EmUrgentCare. Dmand AI also links Dr. Molho to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Molho practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Molho's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Molho is licensed in New York.

CMS data shows 794 Medicare services from Dr. Molho across 11 procedure codes in 2024, for 405 Medicare patients. Medicare paid $53,578 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 405 Medicare patients who saw Dr. Molho in 2024. The largest group is 75 to 84, with 174 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Molho's median patient age at 72, with 49% women.

In 2024, Dr. Molho wrote 3,925 Medicare Part D claims for 509 patients. 92% of them were for generic drugs. CMS names the drug for 3,757 of them, across 56 drugs with 11 or more claims each, at $1,905,513 in total drug cost. In 2023, CMS named 3,833 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Molho for performance year 2024, reported as part of a group. Dr. Molho accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Molho as offering telehealth.

Dmand AI links 13 papers to Dr. Molho, published from 2020 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Parkinson Disease, Disease Models, Animal and Oxidopamine. Dr. Molho has published most often in Neuroscience. Dr. Molho's most frequent co-authors are Julie Georgia Pilitsis, MBA, MD, PhD, Robert A. Hauser, MD and Stuart H. Isaacson, MD.

Dmand AI links Dr. Molho to 1 clinical trial. Open Payments lists research payments to Dr. Molho that name 1 trial.

CMS Open Payments shows 91 general payments to Dr. Molho from 12 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 82% of the total. Neurocrine BioSciences, Inc. paid the most, $47,201. It also lists 2 research payments totaling $4,384 in 2017, naming 1 clinical trial.

Dr. Molho graduated from Albany Medical College in 1987.